Cimeio Therapeutics
Latest round
- Series A
Last raised
- Apr 2022
Total raised
- $50M
Investors
- 1
About Cimeio Therapeutics
Based in Switzerland, and founded in 2020 by Lukas Jeker, Cimeio Therapeutics AG, aka Cimeio, is a patented technological platform working to produce curative medications for people with genetic ailments, hematologic malignancies, and severe autoimmune disorders. The firm will begin clinical trials on its initial projects in 2023.
Who invested in Cimeio Therapeutics
1 investor across 1 round
See all investors in Cimeio Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 13, 2022
Amount
$50M
Investors
Questions about Cimeio Therapeutics
Who invested in Cimeio Therapeutics?
Cimeio Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cimeio Therapeutics raised?
Cimeio Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Cimeio Therapeutics last raise money?
Cimeio Therapeutics's most recent round on record is a Series A, in Apr 2022.
What does Cimeio Therapeutics do?
Based in Switzerland, and founded in 2020 by Lukas Jeker, Cimeio Therapeutics AG, aka Cimeio, is a patented technological platform working to produce curative medications for people with genetic ailments, hematologic malignancies, and severe autoimmune disorders.
Where is Cimeio Therapeutics headquartered?
Cimeio Therapeutics is headquartered in Basel, Switzerland.
Which VCs invest in companies like Cimeio Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Cimeio Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Cimeio Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.